Hi all,Imagion was featured in an article on Biotech Daily late...

Hi all,

Imagion was featured in an article on Biotech Daily late last week that gives an overview of the company’s achievements this year, emphasizing the potential of IBX’s technology and its uniqueness in the market.

Executive Director and CEO Bob Proulx sat down with Tim Boreham to talk about Imagion’s recent milestones with the clinical trial and the impact of COVID and its restrictions on the recruitment of patients.

The interview also touches on the important partnerships announced this year with Patrys and Global Cancer Technology, allowing Imagion to expand its capabilities into different types of cancers and other diseases.

You can read the full article here.